Cargando…
Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives
Gastric cancer (GC) is one of the most common cancers globally, threatening global health. The deregulation of the Hippo signaling pathway has been discovered in GC and may be related to cancer development, proliferation, metastasis, and drug resistance. Yes-associated protein (YAP), as a downstream...
Autores principales: | Yong, Jiaxin, Li, Yuan, Lin, Sihan, Wang, Zhenning, Xu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203099/ https://www.ncbi.nlm.nih.gov/pubmed/34140763 http://dx.doi.org/10.2147/DDDT.S308377 |
Ejemplares similares
-
The current status and future perspectives of laparoscopic surgery for gastric cancer
por: Kim, Hyung-Ho, et al.
Publicado: (2011) -
Current status and future perspectives on neoadjuvant therapy in gastric cancer
por: Ao, Sheng, et al.
Publicado: (2021) -
Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions
por: Li, Zehui, et al.
Publicado: (2023) -
Laparoscopic Surgery for Advanced Gastric Cancer: Current Status and Future Perspectives
por: Uyama, Ichiro, et al.
Publicado: (2013) -
Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges
por: Gan, Lu, et al.
Publicado: (2022)